Syncom Formulations Share Price Target Forecast From 2025 To 2030

Syncom Formulations (India) Ltd is a prominent pharmaceutical company specializing in the manufacturing and marketing of a wide range of healthcare products. As of February 5, 2025, the company's stock is trading at ₹18.10, with a market capitalization of ₹1,703 crore.

In this article, we will analyze Syncom Formulations' current market performance, shareholding structure, and growth potential, along with stock price projections from 2025 to 2030.

Current Performance Overview for Syncom Formulations Share Price

Let's begin by reviewing the latest performance metrics for Syncom Formulations:

• Open Price: ₹17.94
• Previous Close: ₹17.57
• Volume: 1,535,261 shares
• Value (Lacs): Not specified
• VWAP (Volume Weighted Average Price): ₹17.79
• Beta: Not specified
• Market Capitalization: ₹1,703 crore
• High: ₹18.10
• Low: ₹17.57
• Upper Circuit Limit: ₹19.32
• Lower Circuit Limit: ₹15.81
• 52-Week High: ₹27.90
• 52-Week Low: ₹11.00
• Face Value: ₹1
• All-Time High: ₹27.90
• All-Time Low: ₹7.25
• 20-Day Average Volume: 16,792,608
• 20-Day Average Delivery Percentage: Not specified
• Book Value Per Share: ₹3.32
• Dividend Yield: 0.00%

As of now, Syncom Formulations' stock price is ₹18.10, reflecting modest fluctuations within the recent trading range. The 52-week high of ₹27.90 and the low of ₹11.00 indicate a degree of volatility, which may be influenced by factors such as investor sentiment, market trends, and external events.

Shareholding Pattern for Syncom Formulations Share Price

The specific shareholding structure of Syncom Formulations is not detailed in the available sources. However, understanding the distribution between promoters, foreign institutional investors (FIIs), domestic institutional investors (DIIs), and the public is crucial for assessing the company's equity distribution and potential stock stability.

Syncom Formulations Share Price Target Forecast From 2025 To 2030

Considering current market conditions, financial performance, and future growth potential, the projected share price targets for Syncom Formulations from 2025 to 2030 are as follows:

2025 Syncom Formulations Share Price Target: ₹18.10 – ₹19.32

In 2025, Syncom Formulations' stock price is expected to range between ₹18.10 and ₹19.32. This growth is attributed to:

• Product Portfolio Expansion: Introduction of new pharmaceutical products to meet market demand.
• Market Penetration: Enhanced presence in existing markets and entry into new regions.
• Operational Efficiency: Improved manufacturing processes leading to cost reductions.

2026 Syncom Formulations Share Price Target: ₹19.32 – ₹22.00

By 2026, the stock price is projected to range from ₹19.32 to ₹22.00, driven by:

• Strategic Partnerships: Collaborations with other pharmaceutical companies to broaden product offerings.
• Research and Development: Increased investment in R&D for innovative healthcare solutions.
• Regulatory Approvals: Securing approvals for new drugs in domestic and international markets.

2027 Syncom Formulations Share Price Target: ₹22.00 – ₹25.00

In 2027, the stock price is anticipated to rise to between ₹22.00 and ₹25.00, supported by:

• Diversification: Expansion into related healthcare segments such as nutraceuticals.
• Export Growth: Increased export activities to emerging markets.
• Brand Recognition: Strengthening brand presence through marketing initiatives.

2028 Syncom Formulations Share Price Target: ₹25.00 – ₹28.00

By 2028, the stock price is expected to reach ₹25.00 to ₹28.00, facilitated by:

• Technological Advancements: Adoption of advanced manufacturing technologies.
• Sustainable Practices: Implementation of eco-friendly processes enhancing corporate reputation.
• Customer Loyalty: Building a loyal customer base through quality products.

2029 Syncom Formulations Share Price Target: ₹28.00 – ₹32.00

In 2029, the stock price is projected to range between ₹28.00 and ₹32.00, driven by:

• Global Expansion: Establishing a presence in developed international markets.
• Product Innovation: Continuous development of innovative pharmaceutical solutions.
• Operational Excellence: Achieving high standards in production and distribution.

2030 Syncom Formulations Share Price Target: ₹32.00 – ₹36.00

By 2030, Syncom Formulations' stock price is expected to range between ₹32.00 and ₹36.00. This growth will be influenced by:

• Market Leadership: Establishing itself as a key player in the pharmaceutical industry through innovation and expansion.
• International Growth: Strengthening its presence in global markets by increasing exports and forming strategic alliances.
• Diversification: Expanding into high-margin segments like biotechnology, nutraceuticals, and specialty medicines.
• Sustained Revenue Growth: Consistent increase in revenue and profitability driven by strong demand for its products.

Revenue Structure for Syncom Formulations (Past Performance)

Syncom Formulations has demonstrated steady financial growth, with revenue figures reflecting strong business fundamentals:

• FY23: Revenue ₹464 crore | Net Profit ₹37 crore
• FY24 (Estimate): Revenue ₹500 crore | Net Profit ₹42 crore

This consistent growth highlights Syncom Formulations' solid market position and ability to capitalize on increasing healthcare and pharmaceutical demand.

Key Factors Influencing Syncom Formulations' Share Price

Several factors will impact Syncom Formulations' future stock price:

1. Pharmaceutical Industry Growth: Rising healthcare awareness, increasing demand for affordable medicines, and expansion into new therapeutic areas.
2. Regulatory Approvals: Faster approvals for new drugs can boost the company's market presence and revenue streams.
3. Global Expansion: Entering international markets, particularly in emerging economies, can significantly enhance growth prospects.
4. Technological Innovation: Adoption of advanced drug manufacturing techniques and investments in R&D will ensure competitiveness.
5. Strategic Partnerships: Collaborations with domestic and international firms can lead to increased market reach and revenue.

Risks and Challenges

While Syncom Formulations has strong growth potential, certain risks could impact its stock price:

• Regulatory Hurdles: Stringent government regulations and compliance requirements in different countries.
• Market Competition: Competition from established pharmaceutical giants may impact market share and pricing power.
• Economic Slowdown: A slowdown in the economy could affect healthcare spending and demand for medicines.
• Raw Material Costs: Fluctuations in raw material prices may impact profit margins.
• Operational Risks: Delays in drug approvals, production inefficiencies, or supply chain disruptions can affect financial performance.

FAQs

1. What is the projected Syncom Formulations share price in 2025?
The projected share price target for Syncom Formulations in 2025 ranges from ₹18.10 to ₹19.32, driven by market demand, expansion strategies, and financial performance.

2. How does Syncom Formulations' current shareholding pattern affect its stock performance?
A well-balanced shareholding structure with strong promoter holding can ensure price stability, while high public shareholding may lead to increased volatility.

3. What are the key factors driving Syncom Formulations' growth?

• Expansion into new markets
• Investment in R&D
• Strategic partnerships
• Rising demand for pharmaceutical products

4. Is Syncom Formulations a good investment?
Syncom Formulations offers growth potential in the pharmaceutical sector, but investors should consider risks such as competition, regulatory changes, and market volatility before making investment decisions.

Conclusion

Syncom Formulations (India) Ltd has significant growth potential, supported by its strong market position, product innovation, and strategic expansion plans. The projected share price targets from 2025 to 2030 indicate a positive trajectory, making it an attractive option for long-term investors. However, market risks and regulatory factors should be carefully considered before investing.